Test Catalog

Hepatitis B, Antibodies (IgM) anti-core. Screening

Clinical information

Diagnostic Utility:

This is the qualitative detection of IgM antibodies against the core antigen of hepatitis B virus (IgM anti-HBc), and its determination is useful in:

  • Detection of acute hepatitis B virus infection.
  • Transfusion of blood components.
  • Transplantation of progenitor cells, umbilical cord blood, solid organs, and tissues.

Method:

Chemiluminescent Microparticle Immunoassay (CMIA).

Reference Values

Possible results are: Reactive and Non-reactive.

Diagnostic Algorithm:

Not applicable.

Response Time:

Maximum of 2 working days.

Specimen information

Sample: Serum and/or plasma
Tube: 1-5 mL aliquots, plasma tubes with EDTA, sodium citrate, sodium heparin, ACD, CPDA-1, CPD, or potassium oxalate as an anticoagulant and/or serum tubes with or without gel separator.
Minimum essential volume: 1 ml
Stability:

  • At room temperature:  ≤ 3 days
  • In refrigeration 2-8 ºC: ≤ 14 days
  • Sample frozen at or below -20ºC: 10 years

Transport instructions: Preferably at room temperature if they are total blood tubes and refrigerated if they are serum and/or plasma aliquots.

Reason for rejection: Sample highly hemolyzed

Administrative information

BST Code: 0160
Test Description: Anti-
Synonyms: Anti-HBc IgM
Section: Transfusion Safety Laboratory
BST Rate: Check the updated rates here.

Profiles:

The test for antibodies against the core protein of HBV can be requested alone or as part of the profile:

Profile Included Tests
HBV Hepatitis B virus antibodies detection profile

106 Anti-HBc II. Screening

100 Anti-HBs. Screening

160 Anti-HBcIgM. Screening

References

  • Inserts kits de Anti-HBc IgM  Architect, Abbott.